ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,645.99
-1.86%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.434
0.18%
Brent Oil
83.22
-1.33%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Vanda Pharmaceuticals Inc (VNDA)

  7. Vanda Pharmaceuticals Inc (VNDA) ニュース

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VNDA
日付受信時刻ニュースソース見出しコード企業名
2018/03/0521 : 00PR Newswire (US)HETLIOZ® (tasimelteon) Demonstrates Efficacy to Treat Jet Lag Disorder in an 8 Hour Phase Advance Clinical StudyNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/0307 : 46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/0307 : 46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/0307 : 44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/0307 : 43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/0307 : 43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/0207 : 11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/02/1521 : 05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/02/1508 : 49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/02/1507 : 53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/02/1506 : 54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/02/1506 : 01PR Newswire (US)Vanda Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/02/1504 : 30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/02/1503 : 17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/02/1501 : 29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/02/1423 : 02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/02/1001 : 49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/01/3106 : 30PR Newswire (US)Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 14, 2018NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/01/2004 : 32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/01/0822 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/01/0723 : 00PR Newswire (US)Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2017 Revenue Results and 2018 GuidanceNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/01/0507 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/01/0507 : 15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/01/0507 : 14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/01/0507 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/01/0507 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/11/2721 : 30GlobeNewswire Inc.Research Report Identifies Walker & Dunlop, Vanda Pharmaceuticals, Acushnet, SS&C Technologies, ManpowerGroup, and Glaukos wi...NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/11/1323 : 00PR Newswire (US)Vanda Pharmaceuticals Announces Participation at November 2017 Investor ConferencesNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/11/1106 : 05PR Newswire (US)Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatme...NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/11/0821 : 04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VNDA

最近閲覧した銘柄

NASDAQ
GOOGL
Alphabet
COIN
SOLUSD
Solana
AMEX
SPY
SPDR S&P 500
NASDAQ
NVDA
NVIDIA
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
RHHBY
Roche (QX)
NYSE
VZ
Verizon Communications
AMEX
XLF
Financial Select Sector
NYSE
XOM
Exxon Mobil
USOTC
BNPQY
BNP Paribas (QX)
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
CCOM
US500
US 500
FX
USDEUR
US Dollar vs Euro
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有